Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ryoko Okayama"'
Autor:
Minako Shiokawa, Seiki Katakura, Kenji Inoue, Kyoko Shidara, Hiromi Kohmoto, Ryoko Okayama, Taku Kawashima, Takayuki Fujimoto, Ryo Moriyama
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Kenji Inoue, Taku Kawashima, Seiki Katakura, Kyoko Shidara, Takayuki Fujimoto, Hiromi Kohmoto, Minako Shiokawa, Ryo Moriyama, Ryoko Okayama Inouye Eye Hospital, Tokyo, Japan Purpose: To evaluate the efficacy and safety of tafluprost/timolol fixed com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150cdb3f39da2584aad9466458f05aeb
http://europepmc.org/articles/PMC5868587
http://europepmc.org/articles/PMC5868587
Publikováno v:
Clinical Ophthalmology. 2014, Vol. 8, p1275-1279. 5p.
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Kenji Inoue,1 Ryoko Okayama,1 Risako Higa,1 Goji Tomita2 1Inouye Eye Hospital, Tokyo, 2Second Department of Ophthalmology, Toho University School of Medicine, Tokyo, Japan Purpose: We prospectively investigated the intraocular pressure (IOP)-reducing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d6e74f9578bf5590b3ad7a30fbbef5
http://europepmc.org/articles/PMC4086851
http://europepmc.org/articles/PMC4086851
Publikováno v:
International ophthalmology. 38(1)
Ripasudil accelerates aqueous humour drainage along the trabecular meshwork—Schlemm’s canal route and has been approved for clinical use in Japan. We retrospectively investigated the efficacy and safety of adding ripasudil to existing treatment r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2b860a64e8f63fcbe42bd0a27a67f69
https://pubmed.ncbi.nlm.nih.gov/28063100
https://pubmed.ncbi.nlm.nih.gov/28063100
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 27(6)
Latanoprost 0.005%/timolol maleate 0.5% combination eye drops are now available in Japan. The aim of the present study was to investigate the prospective intraocular pressure (IOP) reduction effects and adherence with the combination eye drops in Jap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::375caa7faed2fb852f41633f89711400
https://pubmed.ncbi.nlm.nih.gov/22011049
https://pubmed.ncbi.nlm.nih.gov/22011049
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Background Latanoprost 0.005% + timolol maleate 0.5% combined eyedrops were recently made available in Japan. We prospectively investigated the intraocular pressure (IOP)-lowering effect, visual preservation effect, and adverse reactions of a one-yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eea683d6a7298dcffa141d17fafd446
https://doi.org/10.2147/opth.s30611
https://doi.org/10.2147/opth.s30611